Tag: vaccine-design

Jun 03, 2026

• ANA
• antinuclear-antibody
• dengue
• autoimmunity
• molecular-mimicry
• bystander-activation
• epitope-spreading
• post-dengue
• IIF
• HEp-2
• LIA
• prevalence
• healthy-population
• acute-phase
• IIFA
• FcγRIIa
• NS1
• MAS
• HLH
• macrophage-activation
• NS1-IgG-kinetics
• primary-infection
• PAIgG
• PAIgM
• ANA-negative
• polyreactive-IgM
• nuclear-antigen-consumption
• thrombocytopenia-bifurcation
• immune-complex
• anti-prM
• vaccine-design
• P311-330
• PDI
• epitope-mapping
• FcγRIIa-paradox
• anti-EC-isotype-shift
• dengue-mimickers
• false-positive-serology
• SLE-dengue-differential
• literature-review
• synthesis

Apr 17, 2026

• ADE
• immunopathogenesis
• FcR
• secondary-infection
• severe-dengue
• IGHG1
• plasmablast
• scRNA-seq
• IgG-affinity
• FcgRIIIA
• SPR
• anti-prM
• prM-cleavage
• monocyte
• vaccine-design
• ADE-window
• enhancement-titer
• Katzelnick

Apr 17, 2026

• prM
• pre-membrane-protein
• structural-protein
• virion-maturation
• ADE
• furin-cleavage
• immature-virion
• cross-reactive
• vaccine-design
• molecular-mimicry
• HSP60

Apr 17, 2026

• anti-prM
• ADE
• cross-reactive-antibodies
• neutralisation
• monocyte
• dendritic-cell
• vaccine-design
• prM-cleavage
• monoclonal-antibody
• structural-antibody